Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Histogen Inc (HSTO)

Histogen Inc (HSTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,495
  • Shares Outstanding, K 4,272
  • Annual Sales, $ 3,770 K
  • Annual Income, $ -10,620 K
  • 60-Month Beta 0.92
  • Price/Sales 100.32
  • Price/Cash Flow N/A
  • Price/Book 0.15
Trade HSTO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.81
  • Most Recent Earnings $-0.90 on 11/09/23
  • Latest Earnings Date 05/09/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0501 +598.60%
on 04/19/24
0.5500 -36.36%
on 04/09/24
+0.0250 (+7.69%)
since 03/22/24
3-Month
0.0501 +598.60%
on 04/19/24
0.5500 -36.36%
on 04/09/24
+0.0130 (+3.86%)
since 01/23/24
52-Week
0.0501 +598.60%
on 04/19/24
1.0500 -66.67%
on 05/22/23
-0.6284 (-64.23%)
since 04/21/23

Most Recent Stories

More News
Histogen: Q3 Earnings Snapshot

Histogen: Q3 Earnings Snapshot

HSTO : 0.3500 (unch)
Histogen: Q1 Earnings Snapshot

Histogen: Q1 Earnings Snapshot

HSTO : 0.3500 (unch)
Amerimmune LLC Maintains Intellectual Property on the COVID-19 Related Use of Caspase Inhibitors as a Result of Histogen Inc. Led Arbitration

Amerimmune LLC is a translational medicine biotechnology firm focused on discovery and rapid development of novel therapies for diseases, including COVID-19.

HSTO : 0.3500 (unch)
Histogen (HSTO) Upgraded to Strong Buy: Here's What You Should Know

Histogen (HSTO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

HSTO : 0.3500 (unch)
Histogen: Q3 Earnings Snapshot

Histogen: Q3 Earnings Snapshot

HSTO : 0.3500 (unch)
CEL-SCI Appoints Dr. Gail Naughton to Its Board of Directors

CEL-SCI Corporation (NYSE American: CVM) today announced the appointment of Dr. Gail K. Naughton to its Board of Directors.

CVM : 1.4700 (-2.65%)
ATIS : 0.1000 (-47.37%)
HSTO : 0.3500 (unch)
TXMD : 1.9000 (+1.06%)
Histogen Announces Closing of $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative...

HSTO : 0.3500 (unch)
Histogen Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative...

HSTO : 0.3500 (unch)
Histogen Announces 1-for-20 Reverse Stock Split

SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative...

HSTO : 0.3500 (unch)
Histogen to Present at the H.C. Wainwright Global Investment Conference

SAN DIEGO, May 17, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative...

HSTO : 0.3500 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Histogen Inc. is a regenerative medicine company. It engages in developing patented technologies which replace and regenerates tissues in the body. The company's technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing...

See More

Key Turning Points

3rd Resistance Point 0.3500
2nd Resistance Point 0.3500
1st Resistance Point 0.3500
Last Price 0.3500
1st Support Level 0.3500
2nd Support Level 0.3500
3rd Support Level 0.3500

See More

52-Week High 1.0500
Fibonacci 61.8% 0.6680
Fibonacci 50% 0.5500
Fibonacci 38.2% 0.4321
Last Price 0.3500
52-Week Low 0.0501

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar